Call Us!
Erexafil™: How This Innovative ED Combo Medication Works
Erexafil™ = Tadalafil + Sildenafil + Apomorphine
Erexafil™ is a compounded erectile dysfunction (ED) medication that combines tadalafil, sildenafil, and apomorphine.
While each individual with erectile dysfunction is different, Erexafil™ is a combination medication that acts through multiple, different pathways designed to provide a broader approach to erectile function than a conventional single-drug ED pill.
Sildenafil (Viagra) and tadalafil (Cialis) are PDE5 inhibitors that support the physiological processes responsible for increasing blood flow to the penis during sexual arousal.
Apomorphine works differently, acting through dopamine receptors in the central nervous system involved in sexual response.
Boston Medical Group offers this combination treatment as an option for selected men with ED, including patients who have not achieved the desired response from conventional oral ED medications.
What Is Erexafil™?
Erexafil™ is a physician-prescribed compounded medication containing sildenafil, tadalafil, and apomorphine.
- Sildenafil and tadalafil are established phosphodiesterase type 5 (PDE5) inhibitors used for erectile dysfunction.
- Apomorphine acts through dopaminergic pathways in the brain and central nervous system rather than primarily targeting penile blood flow.
This distinction is central to understanding Erexafil™.
Its formulation combines medications intended to support both the peripheral mechanisms involved in an erection and the central pathways associated with sexual response.
Erexafil™ is not an over-the-counter ED supplement. Because it contains multiple active medications and may not be appropriate for everyone, treatment requires medical evaluation and appropriate prescribing.
What Is in Erexafil™? Explaining Its Key Parts
The three medications in Erexafil™ have different pharmacological actions.
Sildenafil (Viagra)
Sildenafil citrate is the active ingredient in Viagra and belongs to a class of drugs called phosphodiesterase type 5 inhibitors, or PDE5 inhibitors, for short.
During sexual arousal, nitric oxide contributes to the activation of an enzyme called guanylate cyclase, increasing levels of cyclic guanosine monophosphate (cGMP). This signaling helps relax vascular smooth muscle and increase blood flow through the penile arteries and blood vessels supplying erectile tissue.
Phosphodiesterase type 5 breaks down cGMP. However, by inhibiting PDE5, sildenafil helps support the vascular processes necessary for an erection during sexual stimulation.
Tadalafil (Cialis)
Tadalafil, the active ingredient in Cialis, is also a PDE5 inhibitor.
Like sildenafil, tadalafil helps maintain cGMP activity and supports increased penile blood flow during sexual stimulation. However, tadalafil has different pharmacological characteristics and is known for having a longer duration of action than sildenafil.
Other medications, including vardenafil, also belong to the PDE5 inhibitor class, but Erexafil™ specifically combines sildenafil and tadalafil with apomorphine.
Apomorphine
Apomorphine differs from sildenafil and tadalafil because it acts primarily through the central nervous system.
It is a dopamine agonist, meaning it activates dopamine receptors involved in neurological signaling. Dopaminergic activity within areas of the brain, including the hypothalamus, plays a role in sexual behavior and erectile response.
This central action provides a different mechanism from PDE5 inhibition and is an important part of the rationale behind the Erexafil™ combination for treating this type of sexual dysfunction in men.
How Does Erexafil™ Work?
Erexafil™ is designed around a dual-pathway approach to erectile function.
Sildenafil and tadalafil inhibit phosphodiesterase type 5, supporting nitric oxide and cGMP signaling that helps relax smooth muscle in penile blood vessels. During sexual stimulation, this can increase blood flow into the penile tissue and support a firmer erection.
Apomorphine approaches erectile response from another direction. Through its effects on dopamine receptors in the central nervous system, it acts on neurological pathways associated with sexual response.
In simplified terms:
Sildenafil + tadalafil → support penile blood flow
Apomorphine → acts on central dopaminergic pathways involved in sexual response
Sexual arousal is still necessary. Erexafil™ does not simply produce an automatic erection after the medication is taken.
Who May Be a Candidate for Erexafil™?
Boston Medical Group positions Erexafil™ particularly as an option for selected men who have not achieved adequate results from conventional ED pills such as Viagra or Cialis.
There are many reasons why an ED medication may not work as expected.
Erectile dysfunction can involve:
- Vascular disease
- Diabetes
- Nerve problems
- Psychological factors
- Hormonal issues, such as low testosterone
- Medication effects
- A combination of causes
Because Erexafil™ combines multiple pharmacological actions, a physician may consider it when a patient's medical history and previous treatment response suggest that a combination approach is appropriate.
However, Viagra or Cialis not working does not automatically mean Erexafil™ is the right next treatment. Identifying the underlying causes of erectile dysfunction remains an important part of selecting an appropriate treatment.
How Do You Take Erexafil™?
Erexafil™ should be taken according to the specific instructions provided by the prescribing physician.
Boston Medical Group's guidance describes taking Erexafil™ approximately 60 minutes before anticipated sexual activity. Individual response and timing can vary, and patients should follow their prescribed treatment plan rather than changing the dose or combining it with other ED medications independently.
Like other PDE5 inhibitor-based treatments for erectile dysfunction, sexual stimulation is necessary for Erexafil™ to support an erection.
Adequate time for sexual arousal, reduced distractions, moderation with alcohol, and attention to general physical and mental health may also support sexual performance.
What Are the Possible Side Effects of Erexafil™?
Because Erexafil™ combines several active medications, possible side effects can reflect the effects of its individual components.
Sildenafil and Tadalafil Side Effects
Commonly reported effects associated with PDE5 inhibitors can include:
- headache
- facial flushing
- indigestion
- nasal congestion
- back pain
- muscle aches
The likelihood and severity of side effects vary between individuals.
Apomorphine Side Effects
Potential effects associated with apomorphine can include nausea, dizziness, sweating, and fainting. Side effects may depend on the dose and individual response.
Patients should discuss unexpected or concerning symptoms with the physician managing their treatment.
Erexafil™, Nitrates, and Blood Pressure
Medication interactions are particularly important with ED treatments containing PDE5 inhibitors.
PDE5 inhibitors should not be used with nitrates, because the combination can cause a dangerous decrease in blood pressure. Nitrate medications may be prescribed for cardiovascular conditions such as angina.
Patients should tell their physician about their medications and medical conditions, including cardiovascular disease and blood pressure problems, before starting treatment. Erexafil™ should not be combined with Viagra, Cialis, or other erectile dysfunction medications unless specifically directed by the prescribing clinician.
How Is Erexafil™ Different From Viagra or Cialis?
Viagra contains sildenafil, while Cialis contains tadalafil. Both medications primarily treat erection problems by inhibiting PDE5 and supporting increased penile blood flow during sexual stimulation.
Erexafil™ combines sildenafil and tadalafil with apomorphine, adding a medication that acts through dopaminergic pathways in the central nervous system.
The fundamental distinction is therefore not simply that Erexafil™ is another ED pill. Boston Medical Group developed it as a combination ED medication that targets more than one pathway involved in erectile response.
Whether that approach is appropriate depends on the individual patient, the causes of ED, previous treatment results, medical history, and other medications.
How Effective Is Erexafil™?
Boston Medical Group has seen favorable results from Erexafil™ among men who had previously failed to respond adequately to common ED pills.
However, individual treatment response can vary considerably. Erectile dysfunction has many possible causes, and no pharmacological therapy can be expected to work equally well for every patient.
The most useful measure of effectiveness is therefore whether Erexafil™ is appropriate for the patient's specific type of ED and produces an adequate response with acceptable side effects under medical supervision.
Bremetide™ (bremelanotide) is a peptide that has shown great promise as a sexual dysfunction treatment option in selected patients.
Bremelanotide acts through the central nervous system and has a different mechanism from PDE5 inhibitors. Depending on a patient's condition and previous treatment response, Boston Medical Group physicians may consider different treatment strategies involving Erexafil™, Bremetide™, or other approaches.
Combination treatment should be determined by a physician rather than attempted independently.
What If Oral ED Medications Still Don't Work?
Even when oral ED medications fail to produce adequate results, additional erectile dysfunction treatments are available.
Depending on the cause and severity of ED, treatment options may include:
- Alprostadil or Intra-cavernous Pharmacotherapy (penile injections)
- Vacuum erection devices
- Treatment of clinically confirmed testosterone deficiency
- Psychological or sex therapy
- Penile prostheses
Other approaches, including low-intensity extracorporeal shockwave therapy, have also been investigated for certain forms of erectile dysfunction.
The appropriate next step depends on why erections are difficult, rather than simply on whether one particular ED pill worked.
Talk to Boston Medical Group About Erexafil™
Erectile dysfunction treatment does not have to follow a one-size-fits-all approach.
If Viagra, Cialis, or another ED medication has not produced the results you expected, a Boston Medical Group physician can evaluate your symptoms, medical history, previous treatment response, and other health factors to determine whether Erexafil™ or another ED treatment may be appropriate.
Frequently Asked Questions About Erexafil™
What Is Erexafil™?
Erexafil™ is a compounded erectile dysfunction medication that combines sildenafil, tadalafil, and apomorphine. The formulation combines PDE5 inhibition with a medication acting through central dopaminergic pathways involved in sexual response.
What Medications Are in Erexafil™?
Erexafil™ contains sildenafil, tadalafil, and apomorphine. Sildenafil is the active ingredient in Viagra, while tadalafil is the active ingredient in Cialis. Apomorphine acts through dopamine receptors in the central nervous system.
Is Erexafil™ the Same as Viagra?
No. Viagra contains sildenafil citrate as its active ingredient. Erexafil™ combines sildenafil with tadalafil and apomorphine, giving the compounded medication a different formulation and treatment rationale.
Does Erexafil™ Require Sexual Arousal?
Yes. The PDE5 inhibitor components of Erexafil™ support the physiological erectile response to sexual stimulation. Taking the medication does not automatically produce an erection without sexual arousal.
What Are the Side Effects of Erexafil™?
Possible effects associated with its components include headache, flushing, indigestion, nasal congestion, back or muscle aches, nausea, dizziness, sweating, and fainting. Individual reactions vary, and patients should discuss side effects with their prescribing physician.
Can You Take Erexafil™ With Nitrates?
PDE5 inhibitors should not be combined with nitrate medications because the interaction can cause a dangerous decrease in blood pressure. Patients should provide their physician with a complete medication and medical history before using Erexafil™.
